Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 1Rectal Neoplasms 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Colorectal Neoplasms 1Anus Neoplasms 1

Interventions

Fluorouracil 8Radiotherapy 4Mitomycin 4Cyclophosphamide 3Cisplatin 3pembrolizumab 2fludarabine phosphate 2fludarabine 2aldesleukin 2Watchful Waiting 2VGX-3100 2Specimen Handling 2Papillomavirus Vaccines 2Nivolumab 2Magnetic Resonance Spectroscopy 2Light Coagulation 2Ipilimumab 2Cetuximab 2CTLA-4 Antigen 2Biopsy 2tempol 1rocakinogene sifuplasmid 1enzalutamide 1durvalumab 1dehydroftorafur 1alovudine 1abiraterone 1Yoga 1Therapeutics 1SRA737 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Anus Neoplasms × NHS-IL12 immunocytokine × Clear all
NCT04287868 2026-04-13

Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies

National Institutes of Health Clinical Center (CC)

Phase 1/2 Active not recruiting
51 enrolled 16 charts
GastrointestinalGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡